Why choose Neogenesis

The are numerous reasons for your choice:

Since its beginning in 1998, Neogenesis has been a pioneer in all aspects of assisted reproduction with continuous search for new methods and techniques for the improvement of the results.

  • Extension of embryo culture and transfer from the 3rd day to the 4th or 5th day of development, at the blastocyst stage, improving the success rates, which may reach 65% – 70% in some groups of women. More..
  • Treatment with dehydroepiandrosterone (DHEA) for cases of premature ovarian failure (POF) since 2006. This is an innovative method at an international level with very good results, which were published in Fertility and Sterility in 2009. Since then, the therapy was extended to women with premature ovarian ageing (POA) and diminished ovarian reserve (DOR) and poor responders. In any case, the protocols are personalized, aiding even women of 46-47 years. More…
  • Preimplantation genetic diagnosis (PGD). PGD is offered to couples that are carriers or suffer from a genetic disorder and want to avoid an affected with the disorder pregnancy. The PGD patients are coordinated by Dr Thalia Mamas a Geneticist, specialized in PGD. For the diagnosis modern techniques are used like array CGH for the detection of chromosomal abnormalities. More..
  • ICSI (instracytoplasmic sperm injection)/PICSI (Physiological intracytoplasmic sperm injection). More..
  • IMSI (Intracytoplasmic morphologically selected sperm injection). During IMSI, the selection of the single sperm is performed under very high magnification. IMSI increases success rates in couples with oligoasthenoteratospermia and those of advanced maternal age and it decreases the possibility of neonatal abnormalities. More..
  • Assisted hatching. More..
  • Oocyte cryopreservation (vitrification). More..
  • Oocyte donation from selected donors of young age (20-25 years) with increased success rates. More..
  • Surrogacy. More..
  • New sperm insemination method. Following many years of clinical studies, our Centre presented the new method of intrauterine insemination: intrauterine tuboperitoneal sperm insemination (IUTPI). IUTPI uses 10ml of inseminate that includes the spermatozoa and culture medium. The increased volume of inseminate, as well as the use of the DNB cervical clamp especially designed for this purpose by Dr Mamas (with a patent certificate), provides the ability to a larger number of spermatozoa to reach the points where fertilisation normally occurs. This results in three times higher success rates from routine IUI. This technique was published in Fertility and Sterility in 2006. WHO suggests 4-6 insemination attempts before moving to IVF. More..
  • Sperm pooling – The combination of more than one sperm samples, before insemination (from the same man) for the increase of the final number of spermatozoa in the inseminate.
  • Friendly, warm environment aiming in the best customer service towards our patients. Direct communication with Dr Mamas, Director. More..

Neogenesis

  • 3 Kifissias, Maroussi, 15123, Athens, Greece

  • +30 210 6828150-2

  • +30 210 6836090

  • ivf@neogenesis.gr